George Falkay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
George Falkay has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Judit Hohmann
Institute of Pharmacognosy, University of Szeged, Eötvös Str. 6, 6720 Szeged, Hungary
3 shared publications - Aimun Abdelgaffar Elhassan Ahmed
Department of Pharmacology, Faculty of Medicine, Al-Baha University, Al-Baha, Saudi Arabia
2 shared publications Andrea Vasas
Department of Pharmacognosy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary
2 shared publicationsArpad Marki
Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary
2 shared publicationsBalázs Jójárt
Department of Chemical Informatics, Faculty of Education, University of Szeged, Szeged, Hungary
2 shared publicationsRobert Gaspar
Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary
2 shared publications
Latest Publications
- Open Access
- 22 August 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (8) , 1300
The Effects of Female Sexual Hormones on the Expression of Aquaporin 5 in the Late-Pregnant Rat Uterus
Thirteen mammalian aquaporin (AQP) water channels are known, and few of them play a role in the mammalian reproductive system. In our earlier study, the predominance of AQP5 in the late-pregnant rat uterus was proven. Our current aim was to investigate the effect of estrogen- and gestagen-related compounds on the expression of the AQP5 channel in the late-pregnant rat uterus. Furthermore, we examined the effect of hormonally-induced preterm delivery on the expression of AQP5 in the uterus. We treated pregnant Sprague-Dawley rats subcutaneously with 17β-estradiol, clomiphene citrate, tamoxifen citrate, progesterone, levonorgestrel, and medroxyprogesterone acetate. Preterm delivery was induced by subcutaneous mifepristone and intravaginal prostaglandin E2. Reverse-transcriptase PCR and Western blot techniques were used for the detection of the changes in AQP5 mRNA and protein expressions. The amount of AQP5 significantly increased after progesterone and progesterone analogs treatment on 18 and 22 days of pregnancy. The 17β-estradiol and estrogen receptor agonists did not influence the AQP5 mRNA level; however, estradiol induced a significant increase in the AQP5 protein level on the investigated days of gestation. Tamoxifen increased the AQP5 protein expression on day 18, while clomiphene citrate was ineffective. The hormonally-induced preterm birth significantly decreased the AQP5 level similarly to the day of delivery. We proved that AQP5 expression is influenced by both estrogen and progesterone in the late-pregnant rat uterus. The influence of progesterone on AQP5 expression is more predominant as compared with estrogen.
- 22 August 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (8) , 1300
Open AccessThe Effects of Female Sexual Hormones on the Expression of Aquaporin 5 in the Late-Pregnant Rat Uterus
Thirteen mammalian aquaporin (AQP) water channels are known, and few of them play a role in the mammalian reproductive system. In our earlier study, the predominance of AQP5 in the late-pregnant rat uterus was proven. Our current aim was to investigate the effect of estrogen- and gestagen-related compounds on the expression of the AQP5 channel in the late-pregnant rat uterus. Furthermore, we examined the effect of hormonally-induced preterm delivery on the expression of AQP5 in the uterus. We treated pregnant Sprague-Dawley rats subcutaneously with 17β-estradiol, clomiphene citrate, tamoxifen citrate, progesterone, levonorgestrel, and medroxyprogesterone acetate. Preterm delivery was induced by subcutaneous mifepristone and intravaginal prostaglandin E2. Reverse-transcriptase PCR and Western blot techniques were used for the detection of the changes in AQP5 mRNA and protein expressions. The amount of AQP5 significantly increased after progesterone and progesterone analogs treatment on 18 and 22 days of pregnancy. The 17β-estradiol and estrogen receptor agonists did not influence the AQP5 mRNA level; however, estradiol induced a significant increase in the AQP5 protein level on the investigated days of gestation. Tamoxifen increased the AQP5 protein expression on day 18, while clomiphene citrate was ineffective. The hormonally-induced preterm birth significantly decreased the AQP5 level similarly to the day of delivery. We proved that AQP5 expression is influenced by both estrogen and progesterone in the late-pregnant rat uterus. The influence of progesterone on AQP5 expression is more predominant as compared with estrogen.
- 30 December 2011
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 21 (12) , 4100-4107
In silico and in vitro pharmacological investigations of a natural alkaloid
- 30 December 2011
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 21 (12) , 4100-4107
In silico and in vitro pharmacological investigations of a natural alkaloid
- Open Access
- 1 July 2011
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 142 (1) , 175-181
Ontogeny of sulfonylurea-binding regulatory subunits of KATP channels in the pregnant rat myometrium
ATP-sensitive potassium channels (KATP channels) are composed of sulfonylurea receptors (SURs) and potassium inward rectifiers (Kir6.x) that assemble to form a large octameric channel. This study was designed to examine the expression and role of sulfonylurea-binding regulatory subunits 1 (SUR1 (ABCC8)) and 2 (SUR2 (ABCC9)) of the KATP channels in the pregnant rat myometrium with particular regard to the contractility. RT-PCR and western blot analyses were performed to detect the presence of SUR1 and SUR2. The SUR1 levels were markedly increased in the early stages of pregnancy. The highest level was detected on day 6 of pregnancy, whereas in the late stages, the levels of SUR1 were significantly decreased. The SUR2 level remained unchanged throughout pregnancy. The SUR non-selective diazoxide and the SUR2-selective pinacidil inhibited oxytocin-induced contractions. Glibenclamide, a KATP channel blocker, antagonized both pinacidil- and diazoxide-induced relaxations. It was established that SURs are responsible for pharmacological reactivity of KATP channel openers. We conclude that both SURs are involved in the KATP channel in the pregnant rat myometrium. It may further be concluded that ‘pinacidil-like’ KATP channel openers may be of therapeutic relevance as tocolytic agents in the future.
- 1 July 2011
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 142 (1) , 175-181
Open AccessOntogeny of sulfonylurea-binding regulatory subunits of KATP channels in the pregnant rat myometrium
ATP-sensitive potassium channels (KATP channels) are composed of sulfonylurea receptors (SURs) and potassium inward rectifiers (Kir6.x) that assemble to form a large octameric channel. This study was designed to examine the expression and role of sulfonylurea-binding regulatory subunits 1 (SUR1 (ABCC8)) and 2 (SUR2 (ABCC9)) of the KATP channels in the pregnant rat myometrium with particular regard to the contractility. RT-PCR and western blot analyses were performed to detect the presence of SUR1 and SUR2. The SUR1 levels were markedly increased in the early stages of pregnancy. The highest level was detected on day 6 of pregnancy, whereas in the late stages, the levels of SUR1 were significantly decreased. The SUR2 level remained unchanged throughout pregnancy. The SUR non-selective diazoxide and the SUR2-selective pinacidil inhibited oxytocin-induced contractions. Glibenclamide, a KATP channel blocker, antagonized both pinacidil- and diazoxide-induced relaxations. It was established that SURs are responsible for pharmacological reactivity of KATP channel openers. We conclude that both SURs are involved in the KATP channel in the pregnant rat myometrium. It may further be concluded that ‘pinacidil-like’ KATP channel openers may be of therapeutic relevance as tocolytic agents in the future.
- 2 June 2011
- Published by Elsevier in European Journal of Pharmacology
- Vol. 667 (1-3) , 348-354
β2-Adrenergic activity of 6-methoxykaempferol-3-O-glucoside on rat uterus: In vitro and in silico studies
- 2 June 2011
- Published by Elsevier in European Journal of Pharmacology
- Vol. 667 (1-3) , 348-354
β2-Adrenergic activity of 6-methoxykaempferol-3-O-glucoside on rat uterus: In vitro and in silico studies
- 27 July 2007
- Published by Wiley in Phytotherapy Research
- Vol. 21 (12) , 1200-1208
Antiproliferative activity of Hungarian Asteraceae species against human cancer cell lines. Part I
Aqueous and organic extracts of 25 selected species from four tribes of Hungarian Asteraceae were screened in vitro for antiproliferative activity against HeLa (cervix epithelial adenocarcinoma), A431 (skin epidermoid carcinoma) and MCF7 (breast epithelial adenocarcinoma) cells, using the MTT assay. Twenty five of the 228 tested extracts from different parts of the species of Astereae (6), Inuleae (3), Heliantheae (5) and Anthemideae (11) demonstrated a substantial antiproliferative effect (at least 50% inhibition of cell proliferation) at 10 µg/mL against one or more of the cell lines. Complete dose‐response curves were generated and IC50 values were calculated for these active extracts, and their direct cytotoxic effects were determined. In summary, 11 of the tested 25 plants were found to be active and 4 of them (Anthemis ruthenica, Erigeron canadensis, Erigeron annuus and Inula ensifolia) had not been studied previously for either active compounds or anticancer properties. Copyright © 2007 John Wiley & Sons, Ltd.
- 27 July 2007
- Published by Wiley in Phytotherapy Research
- Vol. 21 (12) , 1200-1208
Antiproliferative activity of Hungarian Asteraceae species against human cancer cell lines. Part I
Aqueous and organic extracts of 25 selected species from four tribes of Hungarian Asteraceae were screened in vitro for antiproliferative activity against HeLa (cervix epithelial adenocarcinoma), A431 (skin epidermoid carcinoma) and MCF7 (breast epithelial adenocarcinoma) cells, using the MTT assay. Twenty five of the 228 tested extracts from different parts of the species of Astereae (6), Inuleae (3), Heliantheae (5) and Anthemideae (11) demonstrated a substantial antiproliferative effect (at least 50% inhibition of cell proliferation) at 10 µg/mL against one or more of the cell lines. Complete dose‐response curves were generated and IC50 values were calculated for these active extracts, and their direct cytotoxic effects were determined. In summary, 11 of the tested 25 plants were found to be active and 4 of them (Anthemis ruthenica, Erigeron canadensis, Erigeron annuus and Inula ensifolia) had not been studied previously for either active compounds or anticancer properties. Copyright © 2007 John Wiley & Sons, Ltd.